Schizophrenia - Articles - Page 3

Research Update

Probiotics, Dietary Fiber, and Antipsychotic Weight Gain

July 3, 2023

Jeffrey Cardenas, MD

Jeffrey Cardenas, MD. Dr. Cardenas has no financial relationships with companies related to this material.

Probiotics may reduce metabolic side effects on antipsychotics, but do they need dietary fiber to work?

Expert Q&A

Recognizing and Treating Psychosis in Autism

April 1, 2023

Kristin Cadenhead, MD

Kristin Cadenhead, MD.

Professor of psychiatry. Director, Cognitive Assessment and Risk Evaluation (CARE) Early Psychosis Treatment and Research Program, University of California, San Diego.

Dr. Cadenhead has no financial relationships with companies related to this material.

Is it autism or psychosis or both? Autistic traits and psychotic symptoms can look a lot alike. How common is psychosis in autism? And how can we differentiate co-occurring autistic traits from psychotic symptoms? Dr. Kristin Cadenhead gives us an approach for sorting through the history and addressing these problems separately.

BOOK REVIEWS FOR PSYCHIATRISTS

Using Stories to Color the Stark Lines of Evidence-Based Medicine: Elyn R. Saks

February 9, 2023

Emily E. Whisler, DO and Edmund S. Higgins, MD.

The first in a series of interesting reading for psychiatrists

RESEARCH UPDATE

Pimavanserin Improves Negative Symptoms of Schizophrenia

January 1, 2023

Brian Miller, MD, PhD, MPH

Brian Miller, MD, PhD, MPH. Dr. Miller, author of this educational activity, receives research support from Augusta University, the National Institute of Mental Health, the Brain and Behavior Research Foundation, and the Stanley Medical Research Institute. Relevant financial relationships listed for the author have been mitigated.

Pimavanserin (Nuplazid) is a novel antipsychotic with a narrow FDA-approval in psychosis due to Parkinson’s disease. This large randomized trial tested the drug in negative symptoms of
schizophrenia.

RESEARCH UPDATE

Aripiprazole-Related Psychotic Exacerbations

January 1, 2023

Brian Miller, MD, PhD, MPH.

Brian Miller, MD, PhD, MPH. Dr. Miller, author of this educational activity, receives research support from Augusta University, the National Institute of Mental Health, the Brain and Behavior Research Foundation, and the Stanley Medical Research Institute. Relevant financial relationships listed for the author have been mitigated.

This study identifies a common clinical scenario where aripiprazole may trigger psychotic symptoms.

Throwback Thursday: Ginger Ale and Normal Hallucinations

October 13, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

Is it ever normal to hear voices and is ginger ale really the best treatment for nausea?

Throwback Thursday: Do Antipsychotics Improve Cognition?

October 6, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

Are newer antipsychotics better for cognition than their older, typical forbearers?

CLINICAL UPDATE

Who's Who? A Review of Delusional Misidentification Syndromes

October 1, 2022

Adrienne Grzenda, MD, PhD.

Adrienne Grzenda, MD. Clinical Assistant Professor of Psychiatry & Biobehavioral Sciences, UCLA David Geffen School of Medicine and Olive View UCLA Medical Center, Los Angeles, CA. Dr. Grzenda, author for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

You have probably encountered patients who adamantly insist a loved one has been replaced by an impostor. Here are tips for how to treat them.

RESEARCH UPDATE

Can Pimavanserin Treat Psychosis in Patients With Dementia?

October 1, 2022

James Black, MD

James Black, MD. Dr. Black, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

This study suggests that patients started on pimavanserin for dementia and psychosis should probably continue it to prevent relapse, but we will need more data for clarity given flaws in the study design.